Constellation Brands enters its October 6 print in a peculiar position: a stock that has lost 14% over the past month, a Street that has spent weeks methodically cutting targets, and yet a PE multiple near 9.3x that prices in a great deal of bad news before management says a word.
The analyst picture has not changed direction since the September 29 preview, but it has sharpened. The most recent note, from RBC Capital's Nik Modi on October 2, reaffirmed an Outperform rating with a $185 target, the most bullish number on the Street. JP Morgan's Drew Levine sits at the other end, having cut to $133 from $165 the previous week while maintaining Neutral. Between those two poles, the consensus mean rests near $163, implying more than 40% upside from the current $112.87. That gap would be encouraging if the targets were stable. They are not. Every revision over the past three weeks has moved lower: UBS to $145 from $168, Citigroup to $165 from $185, Evercore ISI to $160 from $175, Barclays to $122 from $132, TD Cowen to $150 from $174, Deutsche Bank to $136 from $150, Jefferies to $135 from $147. The ratings are intact. The numbers keep falling.
What bulls and bears disagree about is whether the compression stops here. The bull case rests on the durability of Modelo Especial and Corona as premium import franchises. Management's FY27 framework still calls for consolidated net sales of -1% to +1%, Beer operating margins of 37% to 38%, and EPS of $11.20 to $11.90. At a PE below 10x on that guidance range, the shares carry meaningful upside if the company can simply hit its own numbers. Bears are less confident in the denominator. Beer marketing is running above 10% of sales in Q2 and Q3, which creates sequential margin headwinds, and the category itself is facing a softening Hispanic consumer backdrop and some longer-term structural pressure. The wine and spirits segment remains a drag, and the Canopy Growth stake plus the Owens-Illinois Mexico joint venture add complexity without meaningfully improving the picture.
Positioning heading into the report is not particularly charged from a short-selling perspective. Short interest has climbed roughly 19% over the past month to about 5% of the free float, a notable build but not an extreme level. Borrow is easy: the cost to borrow has fallen roughly 28% over the past week to 0.28%, and availability is extraordinarily loose relative to the shares already borrowed, leaving no squeeze pressure in the lending market. Options positioning has shifted modestly more bullish than usual. The put/call ratio is at 0.796, about 1.2 standard deviations below its 20-day average of 0.845, close to its 52-week low of 0.70. That tilt toward calls is a mild contrarian signal into a stock already deep in the red. Among peers, TAP gained 2.1% on the week while SAM was roughly flat, keeping the spotlight on STZ's company-specific headwinds rather than a broad sector trade.
The October 6 print will test whether the relentless target-cutting of recent weeks has finally brought Street estimates into alignment with the business's near-term trajectory, or whether the gap between a $163 consensus and a $113 stock reflects something more fundamental about where Constellation's growth profile is headed.
See the live data behind this article on ORTEX.
Open STZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
